Individually Tailored Prophylaxis in Patients With Severe Hemophilia A

NCT00995046 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Hemophilia A

Interventions

DRUG: FVIII
DRUG: FVIII

Sponsor

Hospices Civils de Lyon